Zoetis Company Overview


What is the Stock Ticker for Zoetis?

The stock ticker for Zoetis is ZTS.

Where is the Zoetis headquarters?

Zoetis' headquarters is located in Parsippany, New Jersey, United States.

What Does Zoetis Do?

Zoetis is a global animal health company that develops and produces medicines, vaccines, and diagnostic products for livestock and pets. They work to improve the health and well-being of animals, as well as the productivity and profitability of farmers and veterinarians.

How Does Zoetis Make Money?

Zoetis is a global animal health company that makes money by selling a wide range of animal health products and services. The company's products include vaccines, medicines, diagnostics, and genetic tests for livestock and companion animals. Zoetis also offers a range of services, including technical support, education, and consulting services to veterinarians, livestock producers, and pet owners.

Zoetis generates revenue through the sale of its products and services to customers around the world. The company's products are sold through a variety of channels, including veterinary clinics, feed stores, and online retailers. Zoetis also has a direct sales force that works with large livestock producers and veterinary clinics to promote and sell its products.

In addition to its core animal health business, Zoetis also generates revenue through partnerships and collaborations with other companies in the animal health industry. The company has a number of strategic alliances with other companies to develop and market new products and technologies.

Overall, Zoetis makes money by providing high-quality animal health products and services to customers around the world. The company's focus on innovation, customer service, and strategic partnerships has helped it to become a leader in the animal health industry and a profitable business.

Who Founded Zoetis?

Zoetis was founded by Pfizer in 1952 and became an independent company in 2013.

What is the History of Zoetis?

Zoetis is a global animal health company that was founded in 1952 as a division of Pfizer. The company was originally known as Pfizer Animal Health and focused on developing and manufacturing animal health products such as vaccines, medicines, and diagnostic tests.

In 2012, Pfizer announced that it would spin off its animal health division into a separate company, which would become Zoetis. The company officially became independent in 2013 and began trading on the New York Stock Exchange under the ticker symbol ZTS.

Since its founding, Zoetis has grown to become one of the largest animal health companies in the world, with operations in more than 100 countries and a portfolio of over 300 products. The company's products are used to treat a wide range of animals, including livestock, pets, and wildlife.

Zoetis has also been recognized for its commitment to sustainability and corporate responsibility. The company has been named to the Dow Jones Sustainability Index for six consecutive years and has received numerous awards for its environmental and social initiatives.

What Industry is Zoetis In?

Zoetis is in the pharmaceuticals/veterinary medicine industry.

What Are Zoetis's Competitive Advantages?

1. Strong brand recognition: Zoetis is a well-known and respected brand in the animal health industry, which gives it a competitive advantage over lesser-known competitors.

2. Wide range of products: Zoetis offers a broad range of animal health products, including vaccines, medicines, and diagnostic tools, which allows it to serve a diverse customer base and meet a variety of needs.

3. Research and development capabilities: Zoetis invests heavily in research and development, which enables it to develop innovative products and stay ahead of the competition.

4. Global presence: Zoetis operates in more than 100 countries, giving it a significant global footprint and the ability to serve customers around the world.

5. Strong relationships with customers: Zoetis has built strong relationships with veterinarians, farmers, and other animal health professionals, which helps it to retain customers and attract new ones.

6. Focus on sustainability: Zoetis is committed to sustainability and responsible business practices, which can be a competitive advantage in an industry where consumers are increasingly concerned about environmental and social issues.

What Are Zoetis's Competitive Threats?

Some competitive threats to Zoetis include:

1. Increased competition from other animal health companies, such as Merck Animal Health and Elanco Animal Health.
2. The emergence of new technologies and treatments that could disrupt the animal health industry.
3. Economic downturns that could lead to decreased demand for animal health products and services.
4. Regulatory changes that could impact the company's ability to operate in certain markets.
5. The potential for consolidation within the animal health industry, which could lead to larger competitors with greater resources and market power.

Who Are Some of the Competitors of Zoetis?

Some of the competitors of Zoetis include Merck Animal Health, Elanco Animal Health, Boehringer Ingelheim Animal Health, and Bayer Animal Health.

What Are Some of Zoetis's Products and Services?

Some notable products and services from Zoetis include vaccines and medicines for livestock and companion animals, diagnostic products, genetic testing services, and digital solutions for animal health management. Some specific products include Apoquel for dogs with allergies, Revolution for cats and dogs to prevent fleas and heartworms, and Draxxin for respiratory disease in cattle and swine.

Has Zoetis Acquired any Companies?

Yes, Zoetis has made several notable acquisitions, including Abaxis, Nexvet Biopharma, and Platinum Performance.

More Companies